Posts | Comments

L-Carnitine Market to reach a market size of $219.2 Million by 2025- KBV Research

Contact Us
KBV Research
244 Fifth Avenue, Suite 1407 New York, N.Y. 10001
New York
NY 10001 
United States
Phone:6466616066
pritysingh@kbvresearch.com

Due to the growing consumer awareness of the benefits of L-carnitine supplementation, the industry is anticipated to experience substantial growth during the forecast period. The food and pharmaceutical grade segment recorded the highest market share in 2018 and in the years to come, is projected to witness significant growth. In addition, it is estimated that the increased use of L-carnitine and its animal feed derivatives will fuel market growth over the forecast period.

The Healthcare Product market dominated the Global L-Carnitine Market by Application in 2018, growing at a CAGR of 3.9 % during the forecast period. The Functional Drink market is experiencing a CAGR of 4% during (2019-2025).

The Chemical Synthesis market dominated the Global L-Carnitine Market by Process in 2018, growing at a CAGR of 4.2 % during the forecast period. The Bioprocess market is anticipated to witness a CAGR of 5.1% during (2019-2025).

The North America market dominated the Global L-Carnitine Market by Region in 2018. The Europe market is expected to witness a CAGR of 3.9% during (2019-2025). Additionally, The Asia Pacific market is poised to witness highest CAGR of 5.4% during (2019-2025).

Structural Insights: https://www.kbvresearch.com/l-carnitine-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.
According to a new report Global L-Carnitine Market, published by KBV Research, The Global L-Carnitine Market size is expected to reach $219.2 Million by 2025, rising at a market growth of 4.56% CAGR during the forecast period.

Recent Strategies Deployed in L-Carnitine Market

» Partnerships, Collaborations and Agreements:

Feb-2019: Lonza Consumer Health & Nutrition collaborated with DuPont Nutrition & Health for manufacturing and supplying human milk oligosaccharide (HMO). The collaboration is based upon meeting the demand of infant nutrition sector; Lonza already provides a portfolio of health ingredients for infant nutrition such as Carnipure, a product inclusive of amino acid L-Carnitine.

» Product Launches and Product Expansions:

Oct-2019: Lonza launched new innovative MuscleGuard™ formulation, a unique patent pending ingredient combination comprising a clinically studied ratio of four nutrients such as Lonza’s Carnipure®L-Carnitine, Creatine and Leucine with vitamin D. The solution delivers positive results for recovery and sports performance through increases in muscle strength, activity, and mass.
Apr-2019: Merck introduced BioContinuum buffer delivery platform, a new building block in the BioContinuum Platform for next-generation bioprocessing. The platform offers contiGuous bioprocessing and it is an integrated solution for more efficient buffer delivery and it provides highest level of accuracy and precision in buffer preparation.
Nov-2018: Merck released BioContinuumâ„¢ Platform for the advancement of biotherapeutic drug manufacturing through simplified operations, improved efficiency, and greater quality & consistency.

» Acquisition and Mergers:

Jul-2019: Lonza took over sterile fill and finish facility from Novartis AG, based in Stein (CH). The acquisition helps Lonza Biotech and Pharma’s present parental drug offerings based out of Basel (CH).
May-2019: Ceva signed an agreement to acquire IDT Biologika GmbH’s veterinary biopharmaceutical portfolio. Under the acquisition, IDT will manufacture the human biotechnology vaccines and pharmaceuticals for international and national markets. The acquisition helps Ceva in strengthening its biological innovation and development.

Global L-Carnitine Market Segmentation

By Product

Food & Pharma Grade
Feed Grade

By Process

Chemical Synthesis
Bioprocess

By Application

Healthcare Product
Functional Drink
Medicine
Animal Food

By Geography

North America

US
Canada
Mexico
Rest of North America

Europe

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled
Merck Group
Lonza Group AG
Northeast Pharmaceutical Group Co. Ltd.
Cayman Chemical Company, Inc.
Tokyo Chemical Industry Co. Ltd.
Ceva Sante Animale S.A.
Kaiyuan Hengtai Chemical Co., Ltd.
ChengDa Pharmaceuticals Co., Ltd.
HuangGang HuaYang Pharmaceutical Co., Ltd.
HuBei YuanCheng SaiChuang Technology Co. Ltd.

L-Carnitine Market Related Reports:
North America Market
Europe Market
Asia Pacific Market
LAMEA Market

Leave a Reply